Compare VGM & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VGM | EHAB |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Hospital/Nursing Management |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 565.6M | 481.3M |
| IPO Year | N/A | N/A |
| Metric | VGM | EHAB |
|---|---|---|
| Price | $10.48 | $10.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 186.2K | ★ 368.7K |
| Earning Date | 01-01-0001 | 03-04-2026 |
| Dividend Yield | ★ 4.34% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | N/A | ★ $1,047,800,000.00 |
| Revenue This Year | N/A | $4.56 |
| Revenue Next Year | N/A | $3.97 |
| P/E Ratio | $988.00 | ★ N/A |
| Revenue Growth | N/A | ★ 1.02 |
| 52 Week Low | $8.15 | $6.47 |
| 52 Week High | $10.07 | $10.91 |
| Indicator | VGM | EHAB |
|---|---|---|
| Relative Strength Index (RSI) | 69.43 | 76.51 |
| Support Level | $10.32 | $9.95 |
| Resistance Level | $10.44 | $10.63 |
| Average True Range (ATR) | 0.06 | 0.27 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 88.24 | 85.44 |
Invesco Trust for Investment Grade Municipals is active in the financial services sector. Its investment objective is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.